These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: A phase II study of prazosin hydrochloride in hypertensive subjects.
    Author: Paul RR, Sharma PL, Wahi PL.
    Journal: Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):271-4. PubMed ID: 794002.
    Abstract:
    The antihypertensive action of Prazosin was studied in 20 hypertensive patients. Sixteen patients completed the 36-week treatment period. The drug produced a gradual and sustained fall in both systolic and diastolic blood pressure. The dosage used was 1 mg TDS. Only 2 patients required 2 mg TDS of Prazosin combined with 1 mg per day of polythiazide, and one of these did not respond. No postural hypotension or weight gain was observed. Side-effects were mild and were not troublesome.
    [Abstract] [Full Text] [Related] [New Search]